Sign in Subscribe
Health care industry

McKesson's Healthcare Delivery Systems Launches Trial Script Pilot Program for Upjohn's Vantin

Strategic Insights

— 1 min read

McKesson's Healthcare Delivery Systems (HDS) has initiated a groundbreaking Trial Script electronic starter supply pilot program in five states for The Upjohn Company. This innovative program allows physicians to easily provide patients with a free starter supply of medication, which is then dispensed through a community pharmacy. The pilot program features Upjohn's antibiotic Vantin(R) (cefpodoxime proxetil) Tablets in 100mg and 200mg strengths, with up to four tablets (a two-day supply) available at no cost to the patient. This program marks a significant shift in the pharmaceutical industry, as it offers a more efficient and cost-effective way to manage sampling processes.

Key Takeaways:

  • The Trial Script pilot program is designed to provide a free starter supply of medication to patients, initiated by a physician attaching a sticker or certificate to a written prescription.
  • The program features Upjohn's antibiotic Vantin(R) (cefpodoxime proxetil) Tablets in 100mg and 200mg strengths, with up to four tablets (a two-day supply) available at no cost to the patient.
  • The Trial Script process allows for accurate, real-time prescribing data to be collected, enabling product managers to make critical decisions.
  • The program expands the marketing boundaries of traditional physician-based programs to include costly and controlled substances.
  • HDS designs and manages patient and product support systems, marketing support programs, and reimbursement services using advanced healthcare information technology.
  • The program is indicative of the growing desire among pharmaceutical manufacturers to find creative new ways to supplement traditional methods of providing free starter supplies.

Statistics:

  • Up to four tablets (a two-day supply) of Vantin(R) will be made available at no cost to the patient through the Trial Script pilot program.
  • The pilot program is being launched in five states for The Upjohn Company.
  • HDS is a unit of San Francisco-based McKesson Corp., the leading provider of pharmaceuticals and health care products and services in North America.

Sources:

  • Healthcare Delivery Systems (HDS)
  • McKesson Corp. (NYSE: MCK)
  • The Upjohn Company (NYSE: UPJ)
  • Raymond Esonis, HDS, 602-314-7026

Read more